Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Theratechnologies Reports on its Annual Meeting of Shareholders By: Theratechnologies via GlobeNewswire May 09, 2024 at 16:30 PM EDT MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, reported the voting results from its annual meeting of shareholders held today in a virtual-only setting. Shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term and appointed KPMG LLP as the Company’s auditors for the current fiscal year. All candidates proposed for the position of director were elected in the following proportion: FOR% FORABSTENTION% ABSTENTIONJoseph Arena22,405,047 93.09%1,663,754 6.91%Frank Holler21,008,601 87.29%3,060,200 12.71%Paul Lévesque20,966,427 87.11%3,102,374 12.89%Andrew Molson21,067,050 87.53%3,001,751 12.47%Dawn Svoronos20,964,213 87.10%3,104,588 2.90%Elina Tea21,734,254 90.30%2,334,547 9.70%Dale Weil21,009,681 87.29%3,059,120 12.71%Jordan Zwick23,107,383 96.01%961,418 3.99% Frank Holler will now act as Chair of the Board of Directors of the Company. About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter). Contacts: Investor inquiries:Philippe DubucSenior Vice President and Chief Financial Officerpdubuc@theratech.com1-438-315-6608 Media inquiries:Julie SchneidermanSenior Director, Communications & Corporate Affairscommunications@theratech.com1-514-336-7800 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Theratechnologies Reports on its Annual Meeting of Shareholders By: Theratechnologies via GlobeNewswire May 09, 2024 at 16:30 PM EDT MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, reported the voting results from its annual meeting of shareholders held today in a virtual-only setting. Shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term and appointed KPMG LLP as the Company’s auditors for the current fiscal year. All candidates proposed for the position of director were elected in the following proportion: FOR% FORABSTENTION% ABSTENTIONJoseph Arena22,405,047 93.09%1,663,754 6.91%Frank Holler21,008,601 87.29%3,060,200 12.71%Paul Lévesque20,966,427 87.11%3,102,374 12.89%Andrew Molson21,067,050 87.53%3,001,751 12.47%Dawn Svoronos20,964,213 87.10%3,104,588 2.90%Elina Tea21,734,254 90.30%2,334,547 9.70%Dale Weil21,009,681 87.29%3,059,120 12.71%Jordan Zwick23,107,383 96.01%961,418 3.99% Frank Holler will now act as Chair of the Board of Directors of the Company. About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter). Contacts: Investor inquiries:Philippe DubucSenior Vice President and Chief Financial Officerpdubuc@theratech.com1-438-315-6608 Media inquiries:Julie SchneidermanSenior Director, Communications & Corporate Affairscommunications@theratech.com1-514-336-7800
MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, reported the voting results from its annual meeting of shareholders held today in a virtual-only setting. Shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term and appointed KPMG LLP as the Company’s auditors for the current fiscal year. All candidates proposed for the position of director were elected in the following proportion: FOR% FORABSTENTION% ABSTENTIONJoseph Arena22,405,047 93.09%1,663,754 6.91%Frank Holler21,008,601 87.29%3,060,200 12.71%Paul Lévesque20,966,427 87.11%3,102,374 12.89%Andrew Molson21,067,050 87.53%3,001,751 12.47%Dawn Svoronos20,964,213 87.10%3,104,588 2.90%Elina Tea21,734,254 90.30%2,334,547 9.70%Dale Weil21,009,681 87.29%3,059,120 12.71%Jordan Zwick23,107,383 96.01%961,418 3.99% Frank Holler will now act as Chair of the Board of Directors of the Company. About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter). Contacts: Investor inquiries:Philippe DubucSenior Vice President and Chief Financial Officerpdubuc@theratech.com1-438-315-6608 Media inquiries:Julie SchneidermanSenior Director, Communications & Corporate Affairscommunications@theratech.com1-514-336-7800
